Grünewald TGP, Cidre-Aranaz F, Surdez D, Tomazou EM, de Álava E, Kovar H, et al. Ewing sarcoma. Nat Rev Dis Primers. 2018;4(1):5.

Article  PubMed  Google Scholar 

Haveman LM, Ranft A, Vd Berg H, Smets A, Kruseova J, Ladenstein R, et al. The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing sarcoma. Cancer Med. 2019;8(3):1086–94.

Article  PubMed  PubMed Central  Google Scholar 

Bosma SE, Ayu O, Fiocco M, Gelderblom H, Dijkstra PDS. Prognostic factors for survival in Ewing sarcoma: a systematic review. Surg Oncol. 2018;27(4):603–10.

Article  CAS  PubMed  Google Scholar 

Oberlin O, Deley MC, Bui BN, Gentet JC, Philip T, Terrier P, et al. Prognostic factors in localized Ewing’s tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer. 2001;85(11):1646–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaspar N, Rey A, Bérard PM, Michon J, Gentet JC, Tabone MD, et al. Risk adapted chemotherapy for localised Ewing’s sarcoma of bone: the French EW93 study. Eur J Cancer. 2012;48(9):1376–85.

Article  PubMed  Google Scholar 

Hayashi K, Yamamoto N, Takeuchi A, Miwa S, Igarashi K, Higuchi T, et al. Clinical course of grafted cartilage in osteoarticular frozen autografts for reconstruction after resection of malignant bone and soft-tissue tumor involving an epiphysis. J Bone Oncol. 2020;24:100310.

Article  PubMed  PubMed Central  Google Scholar 

Takeuchi A, Tsuchiya H, Setsu N, Gokita T, Tome Y, Asano N, et al. What are the complications, function, and survival of tumor-devitalized autografts used in patients with limb-sparing surgery for bone and soft tissue tumors? A Japanese Musculoskeletal Oncology Group Multi-institutional Study. Clin Orthop Relat Res. 2023;481(11):2110–24.

Article  PubMed  Google Scholar 

Abudu A, Davies AM, Pynsent PB, Mangham DC, Tillman RM, Carter SR, et al. Tumour volume as a predictor of necrosis after chemotherapy in Ewing’s sarcoma. J Bone Joint Surg Br. 1999;81(2):317–22.

Article  CAS  PubMed  Google Scholar 

Arai Y, Kun LE, Brooks MT, Fairclough DL, Fontanesi J, Meyer WH, et al. Ewing’s sarcoma: local tumor control and patterns of failure following limited-volume radiation therapy. Int J Radiat Oncol Biol Phys. 1991;21(6):1501–8.

Article  CAS  PubMed  Google Scholar 

Aghighi M, Boe J, Rosenberg J, Von Eyben R, Gawande RS, Petit P, et al. Three-dimensional radiologic assessment of chemotherapy response in Ewing sarcoma can be used to predict clinical outcome. Radiology. 2016;280(3):905–15.

Article  PubMed  Google Scholar 

van der Woude HJ, Bloem JL, Hogendoorn PC. Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing’s sarcoma: review of current imaging modalities. Skeletal Radiol. 1998;27(2):57–71.

Article  PubMed  Google Scholar 

Hoang NT, Acevedo LA, Mann MJ, Tolani B. A review of soft-tissue sarcomas: translation of biological advances into treatment measures. Cancer Manag Res. 2018;10:1089–114.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan HY, Morani A, Wang WL, Hess KR, Paulino AC, Ludwig JA, et al. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection. Int J Radiat Oncol Biol Phys. 2015;92(2):349–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gitto S, Corino VDA, Annovazzi A, Milazzo Machado E, Bologna M, Marzorati L, et al. 3D vs. 2D MRI radiomics in skeletal Ewing sarcoma: feature reproducibility and preliminary machine learning analysis on neoadjuvant chemotherapy response prediction. Front Oncol. 2022;12:1016123.

Article  PubMed  PubMed Central  Google Scholar 

Palmerini E, Colangeli M, Nanni C, Fanti S, Marchesi E, Paioli A, et al. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas. Eur J Nucl Med Mol Imaging. 2017;44(2):215–23.

Article  CAS  PubMed  Google Scholar 

Annovazzi A, Ferraresi V, Anelli V, Covello R, Vari S, Zoccali C, et al. [(18)F]FDG PET/CT quantitative parameters for the prediction of histological response to induction chemotherapy and clinical outcome in patients with localised bone and soft-tissue Ewing sarcoma. Eur Radiol. 2021;31(9):7012–21.

Article  CAS  PubMed  Google Scholar 

Righi A, Pacheco M, Palmerini E, Carretta E, Gambarotti M, Longhi A, et al. Histological response to neoadjuvant chemotherapy in localized Ewing sarcoma of the bone: a retrospective analysis of available scoring tools. Eur J Surg Oncol. 2021;47(7):1778–83.

Article  PubMed  Google Scholar 

Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;153:106–20.

Article  Google Scholar 

Ferrari S, Sundby Hall K, Luksch R, Tienghi A, Wiebe T, Fagioli F, et al. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol. Ann Oncol. 2011;22(5):1221–7.

Article  CAS  PubMed  Google Scholar 

Asaftei SD, Puma N, Paioli A, Petraz M, Morosi C, Podda M, et al. Front-line window therapy with temozolomide and irinotecan in patients with primary disseminated multifocal Ewing sarcoma: results of the ISG/AIEOP EW-2 Study. Cancers (Basel). 2021;13(12):3046.

Article  CAS  PubMed  Google Scholar 

Luksch R, Tienghi A, Hall KS, Fagioli F, Picci P, Barbieri E, et al. Primary metastatic Ewing’s family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. Ann Oncol. 2012;23(11):2970–6.

Article  CAS  PubMed  Google Scholar 

Whelan J, Le Deley MC, Dirksen U, Le Teuff G, Brennan B, Gaspar N, et al. High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk Ewing sarcoma: results of Euro-E.W.I.N.G99 and Ewing-2008. J Clin Oncol. 2018;36(31):Jco2018782516.

Article  PubMed  Google Scholar 

Eggli KD, Close P, Dillon PW, Umlauf M, Hopper KD. Three-dimensional quantitation of pediatric tumor bulk. Pediatr Radiol. 1995;25(1):1–6.

Article  CAS  PubMed  Google Scholar 

Sohaib SA, Turner B, Hanson JA, Farquharson M, Oliver RT, Reznek RH. CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol. 2000;73(875):1178–84.

Article  CAS  PubMed  Google Scholar 

Prasad SR, Jhaveri KS, Saini S, Hahn PF, Halpern EF, Sumner JE. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology. 2002;225(2):416–9.

Article  PubMed  Google Scholar 

Womer RB, West DC, Krailo MD, Dickman PS, Pawel BR, Grier HE, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children’s Oncology Group. J Clin Oncol. 2012;30(33):4148–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brennan B, Kirton L, Marec-Bérard P, Gaspar N, Laurence V, Martín-Broto J, et al. Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial. Lancet. 2022;400(10362):1513–21.

Article  CAS  PubMed  Google Scholar 

Lang P, Vahlensieck M, Matthay KK, Johnston JO, Rosenau W, Gooding CA, et al. Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography. Med Pediatr Oncol. 1996;26(5):329–33.

Article  CAS  PubMed  Google Scholar 

Tran LN, Brown MS, Goldin JG, Yan X, Pais RC, McNitt-Gray MF, et al. Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography. Acad Radiol. 2004;11(12):1355–60.

Article  PubMed  Google Scholar 

Oxnard GR, Zhao B, Sima CS, Ginsberg MS, James LP, Lefkowitz RA, et al. Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes. J Clin Oncol. 2011;29(23):3114–9.

Article